Factors associated with mortality in patients with prostate cancer
DOI:
https://doi.org/10.18041/2665-427X/ijeph.1.9635Keywords:
Prostate, cancer, prostatic neoplasms, mortality, risk, survivalAbstract
Objective: To identify factors associated with mortality in patients with prostate cancer.
Methods: An epidemiological design of an analytical observational case-control study nested in a cohort of patients with prostate cancer was performed. Cases were defined as deceased patients and controls were patients who were still alive at the end of the study.
Results: The mortality observed in patients with prostate cancer was 41.8%. The associated factors of dying from prostate cancer were patients aged ≥60 years, living in a rural area, without a partner, overweight, and in advanced stages of the disease including metastasis. The estimated survival in this population was 71% (95%CI: 67.5%-74.6%) during the study period.
Conclusions: The decrease in survival according to years of follow-up coincides with the evidence found in studies in Colombia.
Downloads
References
OMS. Cáncer, Datos y cifras. OMS; 2022. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/cancer
International Agency for Research on Cancer; OMS. Cancer today. IARC; 2020. Disponible en: http://gco.iarc.fr/today/home
American Cancer Society. Prostate Cancer Risk Factors. American Cancer Society; 2020. Disponible en: https://www.cancer.org/cancer/prostate-cancer/causes-risks-prevention/risk-factors.html
Hinata N, Fujisawa M. Racial differences in prostate cancer characteristics and cancer-specific mortality: an overview. World J Mens Health. 2022; 40(2): 217-27. doi: 10.5534/wjmh.210070
Lu W, Chen H, Niu Y, Wu H, Xia D, Wu Y. Dairy products intake and cancer mortality risk: a meta-analysis of 11 population-based cohort studies. Nutr J. 2016; 15(1): 91. doi: 10.1186/s12937-016-0210-9.
Golabek T, Bukowczan J, Chłosta P, Powroźnik J, Dobruch J, Borówka A. Obesity and prostate cancer incidence and mortality: a systematic review of prospective cohort studies. Urol Int. 2014; 92(1):7-14. doi: 10.1159/000351325.
Darcey E, Boyle T. Tobacco smoking and survival after a prostate cancer diagnosis: A systematic review and meta-analysis. Cancer Treat Rev. 2018; 70: 30-40. doi: 10.1016/j.ctrv.2018.07.001.
Bhindi B, Wallis CJD, Nayan M, Farrell AM, Trost LW, Hamilton RJ, et al. The association between vasectomy and prostate cancer: a systematic review and meta-analysis. JAMA Intern Med. 2017; 177(9): 1273-1286. doi: 10.1001/jamainternmed.2017.2791.
Ling S, Brown K, Miksza JK, Howells LM, Morrison A, Issa E, et al. Risk of cancer incidence and mortality associated with diabetes: A systematic review with trend analysis of 203 cohorts. Nutr Metab Cardiovasc Dis. 2021; 31(1): 14-22. doi: 10.1016/j.numecd.2020.09.023.
Klein J, von dem Knesebeck O. Socioeconomic inequalities in prostate cancer survival: A review of the evidence and explanatory factors. Soc Sci Med. 2015; 142: 9-18. doi: 10.1016/j.socscimed.2015.07.006.
Cuenta de Alto Costo. Una mirada al cáncer de próstata en Colombia. Cuenta de Alto Costo; 2021. Disponible en: https://cuentadealtocosto.org/site/cancer/una-mirada-al-cancer-de-prostata-en-colombia/
Hosmer DW, Lemeshow S, Sturdivant RX. Applied logistic regression. Third edition. Wiley series in probability and statistics. Hoboken, New Jersey: Wiley; 2013.
American Cancer Society. Factores de riesgo para el cáncer de próstata. American Cancer Society; 2020. Disponible en: https://www.cancer.org/es/cancer/cancer-de-prostata/causas-riesgos-prevencion/factores-de-riesgo.html
Restrepo JA, Bravo LE, García-Perdomo HA, García LS, Collazos P, Carbonell J. Incidencia, mortalidad y supervivencia al cáncer de próstata en Cali, Colombia, 1962-2011. Salud Publica Mex. 2014; 56(5): 440-447.
Villegas CR, Chacón JA, Sánchez T. Sobrevida en cáncer de próstata de una población del centro de Colombia. Acta Medica Colombiana. 2015; 40(2): 101-108.
Downloads
Published
Versions
- 2023-02-15 (2)
- 2022-06-30 (1)
Issue
Section
License
Copyright (c) 2022 Interdisciplinary Journal of Epidemiology and Public Health
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
-
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
-
NonCommercial — You may not use the material for commercial purposes.
-
NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
